XML 45 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity And Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders’ Equity And Stock-Based Compensation [Abstract]  
Stock Option Activity

Number of Options

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term in Years

Aggregate Intrinsic Value in Millions

Outstanding as of December 31, 2021

2,663,727 

$

11.56 

$

Options granted

104,000 

36.50 

Options exercised

(203,640)

15.56 

Options forfeited/canceled

(34,639)

20.59 

Outstanding as of December 31, 2022

2,529,448 

12.13 

3.94

$

49.6

Vested and expected to vest at December 31, 2022

2,529,448 

12.13 

3.94

$

49.6

Exercisable at December 31, 2022

2,270,464 

$

10.02 

3.43

$

46.9

Information About Stock Options Outstanding

Options outstanding

Options exercisable

Weighted

average

Weighted

Weighted

Number of

remaining

average

Number of

average

Range of exercise prices

outstanding

contractual

exercise

vested

exercise

From

To

options

life (in years)

price

options

price

$

0.95

$

1.88

585,833 

5.6

$

1.51

505,833 

$

1.46

$

3.24

$

3.24

550,000 

3.0

$

3.24

550,000 

$

3.24

$

4.09

$

12.04

536,951 

4.1

$

7.09

512,888 

$

7.07

$

12.39

$

35.00

655,874 

1.6

$

20.82

653,290 

$

20.79

$

36.40

$

77.00

200,790 

8.8

$

52.64

48,453 

$

62.61

2,529,448 

3.9

$

12.13

2,270,464 

$

10.02

Weighted Average Fair Value Of Options Granted

2022

2021

2020

Volatility

151% to 154%

147% to 151%

123% to 139%

Risk-free interest rates

1.98% to 3.69%

1.12% to 1.42%

0.46% to 0.78%

Expected life of option

7.0 years

7.0 years

7 years

Dividend yield

zero

zero

zero

Forfeiture rate

zero

zero

zero

Weighted average fair value of stock options granted

$35.16

$65.83

$6.69

Summary Of Performance Award Activity

Number of Performance Awards

Outstanding as of December 31, 2021

138,055

Granted

Vested

Forfeited/canceled

(130,913)

Outstanding as of December 31, 2022

7,142

Stock-Based Compensation Expense

Years ended December 31,

2022

2021

2020

Research and development

$

1,631 

$

1,302 

$

453 

General and administrative

435 

457 

535 

Total stock-based compensation expense

$

2,066 

$

1,759 

$

988